Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Vivian P Bykerk; Andrew J K Östör; José Alvaro-Gracia; Karel Pavelka; José Andrés Román Ivorra; Winfried Graninger; William Bensen; Michael T Nurmohamed; Andreas Krause; Corrado Bernasconi; Maher Aassi; Jean Sibilia

doi:https://doi.org/10.1007/s10067-015-2932-z

Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Vivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, Karel Pavelka, José Andrés Román Ivorra, Winfried Graninger, William Bensen, Michael T Nurmohamed, Andreas Krause, Corrado Bernasconi, Maher Aassi, Jean Sibilia

Rheumatology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1321
Journal	Clinical Rheumatology
Volume	34
Issue number	7
DOIs	https://doi.org/10.1007/s10067-015-2932-z
Publication status	Published - Jul 2015

Access to Document

https://doi.org/10.1007/s10067-015-2932-z

Cite this

Bykerk, V. P., Östör, A. J. K., Alvaro-Gracia, J., Pavelka, K., Ivorra, J. A. R., Graninger, W., Bensen, W., Nurmohamed, M. T., Krause, A., Bernasconi, C., Aassi, M., & Sibilia, J. (2015). Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical Rheumatology, 34(7), 1321. https://doi.org/10.1007/s10067-015-2932-z

Bykerk, Vivian P ; Östör, Andrew J K ; Alvaro-Gracia, José et al. / Erratum to : Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. In: Clinical Rheumatology. 2015 ; Vol. 34, No. 7. pp. 1321.

@article{817c0b2c90e4409b89f0c3246475c378,

title = "Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice",

author = "Bykerk, {Vivian P} and {\"O}st{\"o}r, {Andrew J K} and Jos{\'e} Alvaro-Gracia and Karel Pavelka and Ivorra, {Jos{\'e} Andr{\'e}s Rom{\'a}n} and Winfried Graninger and William Bensen and Nurmohamed, {Michael T} and Andreas Krause and Corrado Bernasconi and Maher Aassi and Jean Sibilia",

year = "2015",

month = jul,

doi = "https://doi.org/10.1007/s10067-015-2932-z",

language = "English",

volume = "34",

pages = "1321",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "7",

}

Bykerk, VP, Östör, AJK, Alvaro-Gracia, J, Pavelka, K, Ivorra, JAR, Graninger, W, Bensen, W, Nurmohamed, MT, Krause, A, Bernasconi, C, Aassi, M & Sibilia, J 2015, 'Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice', Clinical Rheumatology, vol. 34, no. 7, pp. 1321. https://doi.org/10.1007/s10067-015-2932-z

Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. / Bykerk, Vivian P; Östör, Andrew J K; Alvaro-Gracia, José et al.
In: Clinical Rheumatology, Vol. 34, No. 7, 07.2015, p. 1321.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Erratum to

T2 - Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

AU - Bykerk, Vivian P

AU - Östör, Andrew J K

AU - Alvaro-Gracia, José

AU - Pavelka, Karel

AU - Ivorra, José Andrés Román

AU - Graninger, Winfried

AU - Bensen, William

AU - Nurmohamed, Michael T

AU - Krause, Andreas

AU - Bernasconi, Corrado

AU - Aassi, Maher

AU - Sibilia, Jean

PY - 2015/7

Y1 - 2015/7

U2 - https://doi.org/10.1007/s10067-015-2932-z

DO - https://doi.org/10.1007/s10067-015-2932-z

M3 - Article

C2 - 25943189

SN - 0770-3198

VL - 34

SP - 1321

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 7

ER -

Bykerk VP, Östör AJK, Alvaro-Gracia J, Pavelka K, Ivorra JAR, Graninger W et al. Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical Rheumatology. 2015 Jul;34(7):1321. doi: https://doi.org/10.1007/s10067-015-2932-z